Export Publication

The publication can be exported in the following formats: APA (American Psychological Association) reference format, IEEE (Institute of Electrical and Electronics Engineers) reference format, BibTeX and RIS.

Export Reference (APA) 
M. Filomena Teodoro, Andrade, M. A. P. & Teresa A. Oliveira (2024). Evaluating the Bioequivalence of Treatments Using t-ratios Tests. 7th International Conference on Mathematics and Statistics,.
Export Reference (IEEE) 
M. F. Teodoro et al.,  "Evaluating the Bioequivalence of Treatments Using t-ratios Tests", in 7th Int. Conf. on Mathematics and Statistics, Amarante, Portugal, 2024
Export BibTeX 
@misc{teodoro2024_1791950878143,
	author = "M. Filomena Teodoro and Andrade, M. A. P. and Teresa A. Oliveira",
	title = "Evaluating the Bioequivalence of Treatments Using t-ratios Tests",
	year = "2024",
	howpublished = "Both (printed and digital)",
	url = "https://www.icoms.org/ICoMS2024CFP.pdf"
}
Export RIS 
TY  - CPAPER
TI  - Evaluating the Bioequivalence of Treatments Using t-ratios Tests
T2  - 7th International Conference on Mathematics and Statistics
AU  - M. Filomena Teodoro
AU  - Andrade, M. A. P.
AU  - Teresa A. Oliveira
PY  - 2024
CY  - Amarante, Portugal
UR  - https://www.icoms.org/ICoMS2024CFP.pdf
AB  - The main objective of the work is the application of experimental design and some simple tests (t-ratios) in the evaluation of bioequivalence of two treatments. It is performed the assessment of the
effectiveness of different treatments administered to two groups of patients: the control group and the test group. The comparison of the control group that received the reference medication with the
control group test, which received the drug under study, using a crossover experimental design. It was performed an analysis using t-ratios and considering and inter-subject variability formulation of
the probabilistic model, where the specification of tests for detection of carryover and period effects were considered. The application to a practical case consisted in the validation of the hypothesis of the proposed model took place, where the effects carryover and period were not significant when considering usual levels of significance. About the treatments, we could conclude that there was statistical significance to affirm that the studied pharmaceuticals were not bioequivalent.
ER  -